StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
RaQualia Pharma Inc.
Tokyo Stock Exchange:4579.T
Sector
Location
Market Cap
USD 89.97 M
Share Price
USD 3.68
Avg Daily Volume
298,219
Change (1 day)
2.05%
Change (1 year)
-1.12%
Change (YTD)
50.53%
RaQualia Pharma Inc. Revenue Per Share for the year ending December 31, 2024: USD 0.91
RaQualia Pharma Inc. Revenue Per Share is USD 0.91 for the year ending December 31, 2024, a 46.42% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
-
RaQualia Pharma Inc. Revenue Per Share for the year ending December 31, 2023 was USD 0.62, a -41.22% change year over year.
-
RaQualia Pharma Inc. Revenue Per Share for the year ending December 31, 2022 was USD 1.06, a -7.82% change year over year.
-
RaQualia Pharma Inc. Revenue Per Share for the year ending December 31, 2021 was USD 1.15, a 125.02% change year over year.
-
RaQualia Pharma Inc. Revenue Per Share for the year ending December 31, 2020 was USD 0.51, a -32.79% change year over year.
Competitors
Sumitomo Pharma Co., Ltd.
USD 6.21
4506.T
+0.00
0.07%
Guobang Pharma Ltd.
USD 2.82
605507.SS
-0.01
-0.50%
Eli Lilly and Company
USD 772.87
LLY
-7.80
-1.00%
AbbVie Inc.
USD 187.63
ABBV
-1.65
-0.87%
Novo Nordisk A/S
USD 69.09
NOVO-B.CO
-1.99
-2.80%
Roche Holding AG
USD 342.25
RO.SW
-5.82
-1.67%
Novartis AG
USD 122.10
NOVN.SW
-1.46
-1.18%
Abbott Laboratories
USD 133.70
ABT
-0.74
-0.55%
AstraZeneca PLC
USD 138.95
AZN.L
-2.01
-1.43%
Merck & Co., Inc.
USD 80.90
MRK
-0.03
-0.04%
Amgen Inc.
USD 292.95
AMGN
-5.29
-1.77%
Pfizer Inc.
USD 25.24
PFE
-0.14
-0.55%
Gilead Sciences, Inc.
USD 111.78
GILD
+0.03
0.03%
Sanofi
USD 96.52
SAN.PA
-1.52
-1.55%
Vertex Pharmaceuticals Incorporated
USD 459.41
VRTX
-0.21
-0.05%
Bristol-Myers Squibb Company
USD 46.49
BMY
-0.43
-0.92%
Chugai Pharmaceutical Co., Ltd.
USD 47.25
4519.T
-1.65
-3.37%
GSK plc
USD 18.98
GSK.L
-0.18
-0.96%
CSL Limited
USD 160.25
CSL.AX
-0.71
-0.44%
Zoetis Inc.
USD 157.05
ZTS
-2.13
-1.34%
Key Data
| Date | Revenue Per Share | Free Cash Flow Per Share | Dividend Per Share | Debt to Equity Ratio |
|---|
Competitors
Sumitomo Pharma Co., Ltd.
USD 6.21
4506.T
+0.00
0.07%
Guobang Pharma Ltd.
USD 2.82
605507.SS
-0.01
-0.50%
Eli Lilly and Company
USD 772.87
LLY
-7.80
-1.00%
AbbVie Inc.
USD 187.63
ABBV
-1.65
-0.87%
Novo Nordisk A/S
USD 69.09
NOVO-B.CO
-1.99
-2.80%
Roche Holding AG
USD 342.25
RO.SW
-5.82
-1.67%
Novartis AG
USD 122.10
NOVN.SW
-1.46
-1.18%
Abbott Laboratories
USD 133.70
ABT
-0.74
-0.55%
AstraZeneca PLC
USD 138.95
AZN.L
-2.01
-1.43%
Merck & Co., Inc.
USD 80.90
MRK
-0.03
-0.04%
Amgen Inc.
USD 292.95
AMGN
-5.29
-1.77%
Pfizer Inc.
USD 25.24
PFE
-0.14
-0.55%
Gilead Sciences, Inc.
USD 111.78
GILD
+0.03
0.03%
Sanofi
USD 96.52
SAN.PA
-1.52
-1.55%
Vertex Pharmaceuticals Incorporated
USD 459.41
VRTX
-0.21
-0.05%
Bristol-Myers Squibb Company
USD 46.49
BMY
-0.43
-0.92%
Chugai Pharmaceutical Co., Ltd.
USD 47.25
4519.T
-1.65
-3.37%
GSK plc
USD 18.98
GSK.L
-0.18
-0.96%
CSL Limited
USD 160.25
CSL.AX
-0.71
-0.44%
Zoetis Inc.
USD 157.05
ZTS
-2.13
-1.34%